Adrien Sipos MD

Adrien Sipos MD PhD serves as the President and Chief Medical Officer at Praxico- Life Science Consultancy since 2021, providing strategic leadership in clinical development and medical affairs within the pharmaceutical and biotech industries. Prior roles include Head of Immunology in Late Stage Clinical Development at Biogen from 2019 to 2021 and various leadership positions at Eli Lilly and Company, focusing on medical and regulatory affairs, clinical development, and medical affairs across different markets. Additionally, Adrien holds interim and acting chief medical officer roles at Q32 Bio Inc. and Sail Biomedicines, respectively, and previously served as VP and Head of Global Medical Affairs in Rheumatology at Sanofi Genzyme from 2016 to 2018. Educational background includes an MD from the University of Debrecen and a PhD preparation at the University of Oxford, supplemented by a certificate from Harvard Extension School.